Published in Int J Geriatr Psychiatry on August 01, 1997
Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance. Neurobiol Aging (2010) 2.27
Life- and person-centred help in Mecklenburg-Western Pomerania, Germany (DelpHi): study protocol for a randomised controlled trial. Trials (2012) 1.08
(Cost)-effectiveness of case-management by district nurses among primary informal caregivers of older adults with dementia symptoms and the older adults who receive informal care: design of a randomized controlled trial [ISCRTN83135728]. BMC Public Health (2005) 1.06
Economic considerations in the management of Alzheimer's disease. Clin Interv Aging (2006) 1.03
Effects of the Medicare Alzheimer's disease demonstration on Medicare expenditures. Health Care Financ Rev (1999) 0.87
Potential cost-effectiveness of a family-based program in mild Alzheimer's disease patients. Eur J Health Econ (2004) 0.85
Integrative analysis of multi-dimensional imaging genomics data for Alzheimer's disease prediction. Front Aging Neurosci (2014) 0.80
COMPASS: A computational model to predict changes in MMSE scores 24-months after initial assessment of Alzheimer's disease. Sci Rep (2016) 0.78
Dementia and dementia care. Int J Geriatr Psychiatry (1998) 0.75
Current concepts in mild cognitive impairment. Arch Neurol (2001) 18.09
Influence of social network on occurrence of dementia: a community-based longitudinal study. Lancet (2000) 7.31
A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet (1992) 4.31
Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol (1999) 3.62
Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice. Arch Neurol (2001) 3.19
Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology (2007) 2.72
Heritability for Alzheimer's disease: the study of dementia in Swedish twins. J Gerontol A Biol Sci Med Sci (1997) 2.59
Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol (2007) 2.47
The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. Arch Neurol (2000) 2.37
The appropriateness of drug use in an older nondemented and demented population. J Am Geriatr Soc (2001) 2.30
Education and dementia: what lies behind the association? Neurology (2007) 2.26
Low blood pressure and dementia in elderly people: the Kungsholmen project. BMJ (1996) 2.20
Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. Neurology (1997) 2.14
Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Neurology (2004) 2.10
Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J Neuropathol Exp Neurol (1999) 2.08
An estimate of the worldwide prevalence and direct costs of dementia in 2003. Dement Geriatr Cogn Disord (2006) 2.08
Prevalence of Alzheimer's disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology (1991) 2.05
Simultaneous liquid chromatographic determination of seventeen of the major monoamine neurotransmitters, precursors and metabolites. II. Assessment of human brain and cerebrospinal fluid concentrations. J Chromatogr (1987) 2.04
Vitamin B(12) and folate in relation to the development of Alzheimer's disease. Neurology (2001) 2.04
Scanning electron microscopic study of virulent and avirulent colonies of Neisseria gonorrhoeae. Infect Immun (1975) 2.03
Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer's disease. J Comp Neurol (1997) 1.99
Acute confusional states in elderly patients treated for femoral neck fracture. J Am Geriatr Soc (1988) 1.95
Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging. Proc Natl Acad Sci U S A (1994) 1.91
Defective brain microtubule assembly in Alzheimer's disease. Lancet (1986) 1.89
Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study. Neurology (2010) 1.88
Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study. J Neurol Neurosurg Psychiatry (1998) 1.83
Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study. Neurology (2007) 1.81
Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease. Neurology (1999) 1.78
Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014. J Intern Med (2014) 1.75
Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br J Psychiatry (1979) 1.71
Distribution of different fiber types in human skeletal muscles: effects of aging studied in whole muscle cross sections. Muscle Nerve (1983) 1.70
The occurrence of depressive symptoms in the preclinical phase of AD: a population-based study. Neurology (1999) 1.67
Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study. Neurology (2010) 1.67
Nursing homes in 10 nations: a comparison between countries and settings. Age Ageing (1997) 1.65
Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuroreport (2001) 1.63
The impact of chronic multimorbidity and disability on functional decline and survival in elderly persons. A community-based, longitudinal study. J Intern Med (2009) 1.57
Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement Geriatr Cogn Disord (1998) 1.55
Underdiagnosis and poor documentation of acute confusional states in elderly hip fracture patients. J Am Geriatr Soc (1991) 1.55
Occurrence of dementia in advanced age: the study design of the Kungsholmen Project. Neuroepidemiology (1992) 1.54
Heart failure and Alzheimer's disease. J Intern Med (2014) 1.54
Institutionalization in the elderly: the role of chronic diseases and dementia. Cross-sectional and longitudinal data from a population-based study. J Clin Epidemiol (2001) 1.54
Dementia is the major cause of functional dependence in the elderly: 3-year follow-up data from a population-based study. Am J Public Health (1998) 1.51
Aging and the occurrence of dementia: findings from a population-based cohort with a large sample of nonagenarians. Arch Neurol (1999) 1.50
Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer's disease. Neurobiol Aging (2000) 1.49
Postoperative confusion after anesthesia in elderly patients with femoral neck fractures. Anesth Analg (1987) 1.48
Clinical trials in mild cognitive impairment: lessons for the future. J Neurol Neurosurg Psychiatry (2005) 1.47
Preclinical symptoms of major depression in very old age: a prospective longitudinal study. Am J Psychiatry (1998) 1.43
Treatment of Alzheimer disease with tacrine: a cost-analysis model. Alzheimer Dis Assoc Disord (1997) 1.42
Growth pattern and cell division in Neisseria gonorrhoeae. J Bacteriol (1977) 1.40
The influence of education on clinically diagnosed dementia incidence and mortality data from the Kungsholmen Project. Arch Neurol (2001) 1.38
Mortality from dementia in advanced age: a 5-year follow-up study of incident dementia cases. J Clin Epidemiol (1999) 1.38
Elevated cortical zinc in Alzheimer disease. Neurology (2006) 1.38
Levels of alpha- and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients. Neurosci Lett (2000) 1.37
[More accurate diagnosis could identify patients suitable for tacrine therapy]. Lakartidningen (1996) 1.37
Discrimination of Alzheimer's disease and mild cognitive impairment by equivalent EEG sources: a cross-sectional and longitudinal study. Clin Neurophysiol (2000) 1.37
Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment. Neurosci Lett (1999) 1.32
Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc Natl Acad Sci U S A (1994) 1.31
Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology (2012) 1.31
Risk factors for late-onset Alzheimer's disease: a population-based, case-control study. Ann Neurol (1993) 1.29
Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study. Diabetologia (2009) 1.29
A geriatric-anesthesiologic program to reduce acute confusional states in elderly patients treated for femoral neck fractures. J Am Geriatr Soc (1991) 1.27
Accuracy of the Mini-Mental Status Examination as a screening test for dementia in a Swedish elderly population. Acta Neurol Scand (1993) 1.25
No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes. Arch Neurol (1997) 1.25
Increased expression of brain-derived neurotrophic factor mRNA in rat hippocampus is associated with improved spatial memory and enriched environment. Neurosci Lett (1992) 1.25
Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex. J Neurol Neurosurg Psychiatry (2004) 1.25
Occurrence of cognitive impairment and dementia in the community: a 9-year-long prospective study. Neurology (2008) 1.24
Smoking and the occurrence of Alzheimer's disease: cross-sectional and longitudinal data in a population-based study. Am J Epidemiol (1999) 1.24
Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use. Arch Neurol (1999) 1.23
Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration. Brain Res (1998) 1.23
The increase of perceived exertion, aches and pain in the legs, heart rate and blood lactate during exercise on a bicycle ergometer. Eur J Appl Physiol Occup Physiol (1985) 1.23
Psychotropic drug use in elderly people with and without dementia. Int J Geriatr Psychiatry (2001) 1.23
Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis. Acta Neuropathol (1987) 1.22
The patients dying after long terminal phase have acidotic brains; implications for biochemical measurements on autopsy tissue. J Neural Transm (1985) 1.21
Pathways to Alzheimer's disease. J Intern Med (2014) 1.20
Environmental enrichment and the brain. Prog Brain Res (2002) 1.20
Efforts to establish the reliability of the Resident Assessment Instrument. Age Ageing (1997) 1.19
Influence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine levels in human basal ganglia. J Neural Transm (1976) 1.18
Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old: a community-based prospective study. Am J Epidemiol (1998) 1.18
The RAI-PC: an assessment instrument for palliative care in all settings. Am J Hosp Palliat Care (2003) 1.18
The antidepressant and antiinflammatory effects of rolipram in the central nervous system. CNS Drug Rev (2001) 1.17
Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm. J Am Geriatr Soc (1998) 1.17
Determination of 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and homovanillic acid in brain tissue from an autopsy material. Acta Psychiatr Scand (1974) 1.14
Blood pressure and performance on the Mini-Mental State Examination in the very old. Cross-sectional and longitudinal data from the Kungsholmen Project. Am J Epidemiol (1997) 1.13
Involvement of glutaredoxin-1 and thioredoxin-1 in beta-amyloid toxicity and Alzheimer's disease. Cell Death Differ (2005) 1.13
Life satisfaction among the very old: a survey on a cognitively intact sample aged 90 years or above. Int J Aging Hum Dev (2001) 1.12
Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene. Am J Pathol (1996) 1.12
Personality and lifestyle in relation to dementia incidence. Neurology (2009) 1.12
Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition. Arch Neurol (1996) 1.11
Spatial pattern of cerebral glucose metabolism (PET) correlates with localization of intracerebral EEG-generators in Alzheimer's disease. Clin Neurophysiol (2000) 1.11
An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease. Neurobiol Aging (1987) 1.10
Effects of environmental enrichment on cognitive function and hippocampal NGF in the non-handled rats. Behav Brain Res (1999) 1.10
Natural history of Alzheimer's disease and other dementias: review of the literature in the light of the findings from the Kungsholmen Project. Int J Geriatr Psychiatry (1998) 1.10
APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging. Neurology (2004) 1.10
Environmental enrichment results in higher levels of nerve growth factor mRNA in the rat visual cortex and hippocampus. Behav Brain Res (1998) 1.09
Benzodiazepines may have protective effects against Alzheimer disease. Alzheimer Dis Assoc Disord (1998) 1.09
Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample. Neurology (1999) 1.09
Brain activation in young and older adults during implicit and explicit retrieval. J Cogn Neurosci (1997) 1.09
Aspirin, NSAIDs, risk of dementia, and influence of the apolipoprotein E epsilon 4 allele in an elderly population. Neuroepidemiology (2004) 1.09
Comparison between the Visual Analogue Scale (VAS) and the Category Ratio Scale (CR-10) for the evaluation of leg exertion. Int J Sports Med (1992) 1.08
The prevalence of functional disability in activities of daily living and instrumental activities of daily living among elderly Beijing Chinese. Arch Gerontol Geriatr (2004) 1.08